THE ROLE OF BLOOD GROUPS IN NON-ALCOHOLIC FATTY LIVER DISEASE AND NON-ALCOHOLIC STEATOHEPATITIS

被引:2
|
作者
Karagoz, Hatice [1 ]
Erden, Abdulsamet [2 ]
Ozer, Ozerhan [2 ]
Cetinkaya, Ali [2 ]
Avci, Deniz [2 ]
Gencer, Vedat [2 ]
Arik, Ferhat [2 ]
Kalan, Ugur [2 ]
Gorkem, Hasan [2 ]
Karaman, Hatice [3 ]
Karaman, Ahmet [1 ]
机构
[1] Acibadem Kayseri Hosp, Dept Internal Med, Kayseri, Turkey
[2] Kayseri Training & Res Hosp, Dept Internal Med, Kayseri, Turkey
[3] Kayseri Training & Res Hosp, Dept Clin Pathol, Kayseri, Turkey
来源
ACTA MEDICA MEDITERRANEA | 2017年 / 33卷 / 02期
关键词
ABO; Blood Groups; Non-alcoholic Fatty Liver Disease; Non-alcoholic Steatohepatitis; PREECLAMPSIA; RISK; SEVERITY; FEATURES; FIBROSIS;
D O I
10.19193/0393-6384_2017_2_030
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Non-alcoholic fatty liver disease is defined as the accumulation of fat in the liver in the absence of excessive alcohol consumption or other known pathologies and is a spectrum of disease ranging from steatosis (fat infiltration into the liver) to steatohepatitis. Non-alcoholic steatohepatitis is a more severe form of Non-alcoholic fatty liver disease which is characterised by steatosis, lobular inflammation, ballooning, and fibrosis in liver biopsies. In this study, we aimed to investigate any possible relationship between the ABO/Rh blood group system and Non-alcoholic fatty liver disease /Non-alcoholic steatohepatitis, in Turkey. Materials and methods: A total of 179 patients with hepatosteatosis from Kayseri Training and Research Hospital between the years 2002-2012 were included in the study. The distributions of blood groups of the patients with Non-alcoholic fatty liver disease were compared with the distribution of blood groups of 17.314 healthy donors. The patients were examined for any association between ABO/Rh blood groups and Non-alcoholic fatty liver disease /Non-alcoholic steatohepatitis, and also for an association between ABO/Rh blood groups and grading. Results: Group AB was found to be higher in patients with Non-alcoholic fatty liver disease compared to the control group (p=0.04). The percentage of patients with steatohepatitis was significantly higher in group AB than non-AB blood group (p=0.024). The percentage of patients with steatohepatitis was significantly higher in group grade 3 Non-alcoholic fatty liver disease patients than other two -grade 1 and grade 2 Non-alcoholic fatty liver disease -groups (<0.001). Conclusion: To our knowledge, this is the first analysis in the literature that investigates the association between the ABO blood groups and Non-alcoholic fatty liver disease /Non-alcoholic steatohepatitis. This epidemiological study can not explain the mechanism behind the blood group effect but may be a light for future studies.
引用
收藏
页码:205 / 210
页数:6
相关论文
共 50 条
  • [1] Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
    Eslami, Layli
    Merat, Shahin
    Malekzadeh, Reza
    Nasseri-Moghaddam, Siavosh
    Aramin, Hermineh
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (12):
  • [2] Sex difference in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
    Tomiya, Tomoaki
    HEPATOLOGY RESEARCH, 2010, 40 (01) : 108 - 110
  • [3] CEUS and Fibroscan in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
    Sila Cocciolillo
    Giustino Parruti
    Leonardo Marzio
    World Journal of Hepatology, 2014, (07) : 496 - 503
  • [4] Lifestyle Modifications in Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
    Stavropoulos, Konstantinos
    Imprialos, Konstantinos
    Pittaras, Andreas
    Faselis, Charles
    Narayan, Puneet
    Kokkinos, Peter
    CURRENT VASCULAR PHARMACOLOGY, 2018, 16 (03) : 239 - 245
  • [5] Non-alcoholic fatty liver disease (NAFLD). Non-alcoholic steatohepatitis - NASH
    Keller, KM
    MONATSSCHRIFT KINDERHEILKUNDE, 2004, 152 (08) : 864 - 869
  • [6] Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in patients with HIV
    Verna, Elizabeth C.
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2017, 2 (03): : 211 - 223
  • [7] CEUS and Fibroscan in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
    Cocciolillo, Sila
    Parruti, Giustino
    Marzio, Leonardo
    WORLD JOURNAL OF HEPATOLOGY, 2014, 6 (07) : 496 - 503
  • [8] PTEN in Non-Alcoholic Fatty Liver Disease/Non-Alcoholic Steatohepatitis and Cancer
    Peyrou, Marion
    Bourgoin, Lucie
    Foti, Michelangelo
    DIGESTIVE DISEASES, 2010, 28 (01) : 236 - 246
  • [9] An update on non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in Asia
    Hsu, Ching-Sheng
    Kao, Jia-Horng
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2017, 11 (08) : 759 - 772
  • [10] Surgical Treatment of Non-Alcoholic Steatohepatitis and Non-Alcoholic Fatty Liver Disease
    Weiner, R. A.
    DIGESTIVE DISEASES, 2010, 28 (01) : 274 - 279